- Home
- WAFU vs NCNA Comparison
WAFU vs NCNA Comparison
Compare WAFU & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WAFU | NCNA |
|---|---|---|
| Founded | 1999 | 1997 |
| Country | China | United Kingdom |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8M | 5.7M |
| IPO Year | 2017 | 2017 |
Fundamental Metrics
Financial Performance| Metric | WAFU | NCNA |
|---|---|---|
| Price | $1.38 | $1.41 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 893.3K | 67.8K |
| Earning Date | 07-31-2026 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.22 | $1.21 |
| 52 Week High | $3.06 | $7.01 |
Technical Indicators
Market Signals| Indicator | WAFU | NCNA |
|---|---|---|
| Relative Strength Index (RSI) | 47.89 | 46.27 |
| Support Level | $1.33 | $1.21 |
| Resistance Level | $1.73 | $2.27 |
| Average True Range (ATR) | 0.09 | 0.11 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 44.11 | 13.96 |
Price Performance
Historical ComparisonAbout WAFU Wah Fu Education Group Limited
Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions, and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States and the United Kingdom.